Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

Vishay Intertechnology Releases 1.5 kV Automotive and Commercial IHDV Inductors in Compact Sizes Starting with 20 mm x 14 mm x 14 mm

Vishay Intertechnology Releases 1.5 kV Automotive and Commercial IHDV Inductors in Compact Sizes Starting with 20 mm x 14 mm x 14 mm

Vishay Intertechnology announced the release of its new IHDV line of high-voltage power inductors designed for automotive, energy, and industrial applications. These inductors offer 1.5 kV isolation voltage, compact size, high temperature operation up to 180 °C, and improved soft saturation behavior, enabling stable inductance under load and enhanc…

Independent Bank Corporation Announces Shareholder Approval to Acquire HCB Financial Corp. and Highpoint Community Bank

Independent Bank Corporation Announces Shareholder Approval to Acquire HCB Financial Corp. and Highpoint Community Bank

Independent Bank Corporation (NASDAQ: IBCP) announced that shareholders of HCB Financial Corp. have approved the company's acquisition by Independent Bank. The transaction, previously approved by regulatory authorities, is expected to be completed by July 1, 2026, expanding Independent Bank's assets and branch presence in Michigan.

Genco Shipping & Trading Limited Shareholders Overwhelmingly Re-Elect All Genco Director Nominees at 2026 Annual Meeting

Genco Shipping & Trading Limited Shareholders Overwhelmingly Re-Elect All Genco Director Nominees at 2026 Annual Meeting

Genco Shipping & Trading Limited announced that its shareholders overwhelmingly re-elected all six board director nominees at the 2026 Annual Meeting, reflecting strong support for the company's leadership and comprehensive value strategy. Shareholders also approved the equity incentive plan and ratified the shareholder rights agreement, rejecting …

CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

CervoMed Inc., a clinical-stage biotech company developing treatments for age-related brain disorders, announced a registered direct offering of 2.5 million shares at $4.00 per share, expected to raise $10 million before expenses. The net proceeds will be used for working capital and general corporate purposes to support ongoing clinical trials and…

Keystone Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 22, 2026.

Keystone Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 22, 2026.

Keystone Acquisition Corp., a Nasdaq-listed blank check company (Ticker: KEYYU), announced that its Class A ordinary shares and warrants, initially bundled in units sold during its IPO completed on June 4, 2026, will start trading separately on or about June 22, 2026. The original units will continue trading under the existing ticker, while shares …

Forefront Tech Holdings Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 22, 2026

Forefront Tech Holdings Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 22, 2026

Forefront Tech Holdings Acquisition Corp announced that starting June 22, 2026, holders of its units from the IPO may elect to separate and trade Class A ordinary shares and warrants individually on Nasdaq. The Class A shares will trade under 'FTHA' and the warrants under 'FTHAW', while unseparated units continue as 'FTHAU'. The company is a Cayman…

First Fed Bank Names Chris Walsh Chief Banking Officer

First Fed Bank Names Chris Walsh Chief Banking Officer

First Northwest Bancorp (NASDAQ: FNWB), through its subsidiary First Fed Bank, has appointed Chris Walsh as Chief Banking Officer. Walsh brings over 40 years of banking experience, including leadership roles aimed at growth and community banking development. This strategic hire is part of First Fed's plan to enhance its banking functions, support c…

SEGG Media Reports Strong Q2 Momentum Across Veloce and Quadrant

SEGG Media Reports Strong Q2 Momentum Across Veloce and Quadrant

SEGG Media highlighted robust commercial growth in Q2 2026, fueled by the acquisition of Veloce and expanding partnerships across Veloce Media Group and Quadrant. The company secured new and extended collaborations with major brands in gaming, motorsport, financial services, and consumer sectors, contributing to revenue growth and reinforcing its p…

Edible Garden Announces Adjournment of Annual Meeting to Facilitate Additional Shareholder Participation

Edible Garden Announces Adjournment of Annual Meeting to Facilitate Additional Shareholder Participation

Edible Garden AG Incorporated announced the adjournment of its 2026 Annual Meeting of Stockholders to June 25, 2026, aiming to allow additional time for shareholder voting and broader participation. The proposals remain unchanged, and previously submitted proxies continue to be valid. The company operates in controlled environment agriculture, focu…

New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)

New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)

Longeveron Inc., a clinical-stage biotech company focusing on stem cell therapies, announced that additional analysis from its Phase 2a trial of laromestrocel in mild Alzheimer's disease has been accepted for presentation at the 2026 Alzheimer’s Association International Conference. The data supports the therapeutic potential of laromestrocel and e…

Xometry Expands Injection Molding Platform with a Wider Selection of Materials, On-Demand Expert Access and One-Click Reordering

Xometry Expands Injection Molding Platform with a Wider Selection of Materials, On-Demand Expert Access and One-Click Reordering

Xometry, Inc. (NASDAQ: XMTR) announced new features for its injection molding platform, including an expanded catalog of materials, free on-demand Design for Manufacturability consultations, and a one-click reordering system that streams orders to original suppliers. These enhancements aim to improve design accuracy, speed, and procurement efficien…

Odysight.ai® Receives Purchase Order from Honeywell Aerospace APU Division to Launch Proof of Concept of Odysight.ai's Advanced Predictive Maintenance Vision-Based Monitoring System on Honeywell Aerospace Auxiliary Power Units Portfolio

Odysight.ai® Receives Purchase Order from Honeywell Aerospace APU Division to Launch Proof of Concept of Odysight.ai's Advanced Predictive Maintenance Vision-Based Monitoring System on Honeywell Aerospace Auxiliary Power Units Portfolio

Odysight.ai has secured a purchase order from Honeywell Aerospace APU Division for a proof-of-concept deployment of its advanced visual sensing and AI-driven predictive maintenance platform. The collaboration will initially focus on monitoring the air intake of Honeywell's Auxiliary Power Units to improve fault detection, reduce unplanned downtime,…

AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

AIM ImmunoTech announced that the final subject has received their first dose in the Phase 2 DURIPANC clinical trial evaluating Ampligen in combination with Imfinzi for metastatic pancreatic cancer. The trial's primary endpoint analysis is expected to start in December 2026 with topline results anticipated in Q1 2027. The company aims to use explor…

Nexxen and L2 Data Launch VoterMatch, Bringing Greater Precision, Transparency and Performance to Political Advertising

Nexxen and L2 Data Launch VoterMatch, Bringing Greater Precision, Transparency and Performance to Political Advertising

Nexxen, traded on Nasdaq as NEXN, has partnered with L2 Data to introduce VoterMatch, a solution that integrates Nexxen's log-level DSP data with L2's National Voter File to provide political advertisers with precise and transparent insights into voter reach and frequency, improving campaign efficiency and reducing wasted impressions. This innovati…

Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease

Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease

Cadrenal Therapeutics announced plans to file for FDA Rare Pediatric Disease Designation for its anticoagulant tecarfarin as a treatment for pediatric patients with Kawasaki disease who develop coronary artery aneurysms. Tecarfarin offers a novel mechanism with potential advantages over warfarin, aiming to provide more stable anticoagulation in chi…